Spectrum of CREBBP gene dosage anomalies in Rubinstein–Taybi Syndrome patients

[1]  Isabelle Guisle,et al.  Testing and improving experimental parameters for the use of low molecular weight targets in array‐CGH experiments , 2006, Human mutation.

[2]  T. Haaf,et al.  Evidence for a new contiguous gene syndrome, the chromosome 16p13.3 deletion syndrome alias severe Rubinstein–Taybi syndrome , 2006, Human Genetics.

[3]  E. Seemanová,et al.  DNA sequencing of CREBBP demonstrates mutations in 56% of patients with Rubinstein–Taybi syndrome (RSTS) and in another patient with incomplete RSTS , 2005, Human Genetics.

[4]  Johan T den Dunnen,et al.  Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease. , 2005, American journal of human genetics.

[5]  B. D. de Vries,et al.  Screening for subtelomeric rearrangements in 210 patients with unexplained mental retardation using multiplex ligation dependent probe amplification (MLPA) , 2004, Journal of Medical Genetics.

[6]  E. Girodon,et al.  Rapid detection of CFTR gene rearrangements impacts on genetic counselling in cystic fibrosis , 2004, Journal of Medical Genetics.

[7]  C. Rooryck,et al.  Molecular characterization of an 11q14.3 microdeletion associated with leukodystrophy , 2004, European Journal of Human Genetics.

[8]  D. Lacombe,et al.  Analysis of CBP (CREBBP) gene deletions in Rubinstein‐Taybi syndrome patients using real‐time quantitative PCR , 2004, Human mutation.

[9]  B. Ceulemans,et al.  Subtelomeric deletions detected in patients with idiopathic mental retardation using multiplex ligation‐dependent probe amplification (MLPA) , 2004, Human mutation.

[10]  Dominique Stoppa-Lyonnet,et al.  Rapid detection of novel BRCA1 rearrangements in high‐risk breast‐ovarian cancer families using multiplex PCR of short fluorescent fragments , 2002, Human mutation.

[11]  C. Cruaud,et al.  Molecular analysis of the CBP gene in 60 patients with Rubinstein-Taybi syndrome , 2002, Journal of medical genetics.

[12]  C. Scriver.  The Metabolic and Molecular Bases of Inherited Disease , 2001 .

[13]  R. Hennekam,et al.  Diagnostic analysis of the Rubinstein-Taybi syndrome: five cosmids should be used for microdeletion detection and low number of protein truncating mutations , 2000, Journal of medical genetics.

[14]  S. Balcı,et al.  FISH studies in 45 patients with Rubinstein-Taybi syndrome: deletions associated with polysplenia, hypoplastic left heart and death in infancy , 1999, European Journal of Human Genetics.

[15]  D. Lacombe,et al.  Submicroscopic deletion of chromosome 16p13.3 in patients with Rubinstein-Taybi syndrome. , 1998, American journal of medical genetics.

[16]  H. Döhner,et al.  Matrix‐based comparative genomic hybridization: Biochips to screen for genomic imbalances , 1997, Genes, chromosomes & cancer.

[17]  L. Deaven,et al.  Construction of a 1.2-Mb contig surrounding, and molecular analysis of, the human CREB-binding protein (CBP/CREBBP) gene on chromosome 16p13.3. , 1997, Genomics.